#USA #Boston #CDMO Services #Elevaris Medical #Procedural Needles

Elevaris Medical Devices Unveils Expansion in EMEA Region

On November 4, 2025, at the highly anticipated medical technology trade fair COMPAMED in Düsseldorf, Elevaris Medical Devices announced its entry into the EMEA market with an impressive range of contract development and manufacturing organization (CDMO) services, as well as a portfolio of specialized procedural needles. This strategic move follows the recent acquisition of XL Precision Technologies by Spectra Medical Devices, marking a significant step in establishing Elevaris as a key player in the medical device industry.

Richard Zrebiec, the CEO of Elevaris Medical Devices, expressed excitement about the company’s debut at COMPAMED, stating, "We have combined two long-standing companies with highly complementary capabilities, and we are thrilled to bring these offerings to the largest stage in Europe for medical device manufacturers."

Extensive CDMO Services

As a leading CDMO, Elevaris is positioned to provide a wide array of manufacturing specialties geared towards assisting medical device manufacturers worldwide. The company excels in the production of precision micro-components, complex tubular components, and the assembly of intricate sub-assemblies. Notably, Elevaris has established itself as one of the world’s premier manufacturers of customized procedural needles.

The company leverages advanced technologies to deliver high-quality products to its clients, which include:

• - Laser Technology: Incorporating photonic systems that offer cutting, welding, marking, sintering, and abrasion solutions.
• - Micro-Machining: Utilizing Electrical Discharge Machining (EDM), micro-laser cutting, high-speed turning, and milling techniques to achieve precision manufacturing.
• - Precision Forming: Enabling mass production of complex components with micron-level accuracy.
• - Metal Finishing: Enhancing surface properties, functionality, and biocompatibility of medical devices.
• - Specialized Needle Manufacturing: This includes a variety of grinding technologies, from standard conical grinds to specialized designs, as well as injection molding and insert molding techniques for producing precision parts.
• - Cleanroom Assembly: Facilitating both manual and automated assembly of delivery systems and instruments within controlled environments.

A Comprehensive Portfolio

Elevaris’s procedural needle portfolio for the EMEA region includes an extensive selection of radiofrequency needles, accessible through distributors, kit packagers, and private label brands. The company is committed to offering a solid range of CE-marked products, which consist of both packaged sterile devices and non-sterile options available in bulk.

Commitment to Quality and Collaboration

Elevaris Medical Devices places a strong emphasis on leveraging its extensive knowledge, collaborative approach, and manufacturing capabilities to provide value-driven design, development, and production solutions. Its EMEA commercial team, based in Paris, includes dedicated sales and manufacturing experts tailored to meet the needs of clients across the UK and Ireland.

Companies and health organizations interested in learning more about Elevaris's offerings can visit booth 8BM25 at the COMPAMED fair or reach out through email at [email protected].

About Elevaris Medical Devices

Elevaris Medical Devices operates as a contract development and manufacturing organization catering to leading multinational healthcare companies, medical device manufacturers, and emerging technology enterprises. It is one of the top global manufacturers of customized procedural needles and specializes in the production of precision micro-components, complex tubular components, and sub-assemblies. Additionally, the company distributes a broad range of complementary pharmaceutical products, surgical instruments, and medical supplies.

With a workforce of over 300 employees across its North American, UK, and South Korean operations, Elevaris is positioned to make significant contributions to the medical technology landscape. For further information, please visit elevareismedical.com.